EUVIMEDSkopri EUVIMED
Crossref

Concerted pH‐Responsive Performance of Chitosan–Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption

Watunyu Thanongsak iD, Marie Kawahara iD, Masahiko Nakamoto iD, Kenta Homma iD, Amornpun Sereemaspun iD, Wanpen Tachaboonyakiat iD, Uracha Ruktanonchai iD, Keitaro Yoshimoto iD, Ryohei Katayama iD, Michiya Matsusaki iD, Suwabun Chirachanchai iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.202500587 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Watunyu Thanongsak and 10 co-authors. Institution: Center of Excellence in Bioresources to Advanced Materials (B2A-CE), The Petroleum and Petrochemical College, Chulalongkorn University, Bangkok, 1033…. Major MEDLINE topics: Chitosan, Deoxycholic Acid, Antineoplastic Agents, Polymers. Cited 2 times so far (Crossref); 31 references. Funded by: NRCT-JSPS Joint Research Program, High-Potential Research Team Grants National Research Council of Thailand (NRCT), National Research Council of Thailand.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Molecular blocks (MBs) offer a drug‐free approach to cancer therapy by utilizing polymeric nanoparticles that remain dispersed in the bloodstream but aggregate within the acidic tumor microenvironment (pH 6.3–6.5) to disrupt cancer cell membranes. Herein, a pH‐responsive polymeric MB is developed by conjugating deoxycholic acid (DCA) to chitosan (CS) through a water‐based modification using CS succinate (CS‐S). The resulting CS‐S–DCA nanoparticles exhibit significant aggregation at pH 6.2 while maintaining a smaller size at physiological pH (7.4), demonstrating pH‐triggered behavior. This leads to selective cytotoxicity against cancer cell lines (MiaPaCa‐2, A‐549, and HT‐29) while preserving compatibility with normal human dermal fibroblasts. Fluorescence imaging confirms preferential adhesion of CS‐S–DCA to cancer cells over normal cells. Encouraged by these findings, in vivo studies in a mouse model are conducted, which reveal significant tumor suppression without the use of conventional drugs. This work highlights the potential of concerted pH‐responsive polymeric MBs as a promising and biocompatible strategy for drug‐free cancer therapy.

Subjects

MeSH terms (MEDLINE)

ChitosanDeoxycholic AcidAntineoplastic AgentsPolymersHumansHydrogen-Ion ConcentrationAnimalsMiceCell Line, TumorNanoparticlesDrug Screening Assays, AntitumorCell SurvivalCell Proliferation

Author keywords

cancer cellschitosandeoxycholic acidmolecular blockpH‐responsive

Substances

ChitosanDeoxycholic AcidAntineoplastic AgentsPolymers

Authors and institutions

  • Center of Excellence in Bioresources to Advanced Materials (B2A-CE), The Petroleum and Petrochemical College, Chulalongkorn University, Bangkok, 10330, Thailand.
  • Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research (JFCR), Tokyo, 135-8550, Japan.
  • Division of Applied Chemistry, Graduate School of Engineering, Osaka University, Osaka, 565-0871, Japan.
  • Center of Excellence in Nanomedicine, Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok, 10300, Thailand.
  • Department of Materials Science, Faculty of Science, Chulalongkorn University, Bangkok, 10300, Thailand.
  • National Nanotechnology Center, National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.

ORCID profiles: Watunyu Thanongsak, Marie Kawahara, Masahiko Nakamoto, Kenta Homma, Amornpun Sereemaspun, Wanpen Tachaboonyakiat, Uracha Ruktanonchai, Keitaro Yoshimoto, Ryohei Katayama, Michiya Matsusaki, Suwabun Chirachanchai

Funding

  • NRCT-JSPS Joint Research Program
  • High-Potential Research Team Grants National Research Council of Thailand (NRCT)
  • National Research Council of Thailand
  • The Second Century Fund (C2F), Chulalongkorn University
  • 90th Anniversary of Chulalongkorn University, Rachadapisek Sompote Fund

Cite

APA

Thanongsak, W., Kawahara, M., Nakamoto, M., Homma, K., Sereemaspun, A., Tachaboonyakiat, W., Ruktanonchai, U., Yoshimoto, K., Katayama, R., Matsusaki, M., & Chirachanchai, S. (2026). Concerted pH‐Responsive Performance of Chitosan–Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption. ChemMedChem. https://doi.org/10.1002/cmdc.202500587

Vancouver

Thanongsak W, Kawahara M, Nakamoto M, Homma K, Sereemaspun A, Tachaboonyakiat W, et al. Concerted pH‐Responsive Performance of Chitosan–Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption. ChemMedChem. 2026. doi:10.1002/cmdc.202500587

BibTeX
@article{Thanongsak2026,
  author = {Thanongsak, Watunyu and Kawahara, Marie and Nakamoto, Masahiko and Homma, Kenta and Sereemaspun, Amornpun and Tachaboonyakiat, Wanpen and Ruktanonchai, Uracha and Yoshimoto, Keitaro and Katayama, Ryohei and Matsusaki, Michiya and Chirachanchai, Suwabun},
  title = {Concerted pH‐Responsive Performance of Chitosan–Deoxycholic Acid as a Polymeric Molecular Block for Cancer Cell Disruption},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.202500587}
}
Start for free →